Cargando…

Quantification of myocardial (99m)Tc-labeled bisphosphonate uptake with cadmium zinc telluride camera in patients with transthyretin-related cardiac amyloidosis

PURPOSE: We aimed to compare different methods for semi-quantitative analysis of cardiac retention of bone tracers in patients with cardiac transthyretin amyloidosis (ATTR). METHODS: Data from 67 patients with ATTR who underwent both conventional whole-body scan and a CZT myocardial SPECT (DSPECT, S...

Descripción completa

Detalles Bibliográficos
Autores principales: Manrique, Alain, Dudoignon, David, Brun, Stéphanie, N’Ganoa, Catherine, Cassol, Emmanuelle, Legallois, Damien, Lavie-Badie, Yoan, Agostini, Denis, Lairez, Olivier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6928186/
https://www.ncbi.nlm.nih.gov/pubmed/31873816
http://dx.doi.org/10.1186/s13550-019-0584-8
_version_ 1783482429533585408
author Manrique, Alain
Dudoignon, David
Brun, Stéphanie
N’Ganoa, Catherine
Cassol, Emmanuelle
Legallois, Damien
Lavie-Badie, Yoan
Agostini, Denis
Lairez, Olivier
author_facet Manrique, Alain
Dudoignon, David
Brun, Stéphanie
N’Ganoa, Catherine
Cassol, Emmanuelle
Legallois, Damien
Lavie-Badie, Yoan
Agostini, Denis
Lairez, Olivier
author_sort Manrique, Alain
collection PubMed
description PURPOSE: We aimed to compare different methods for semi-quantitative analysis of cardiac retention of bone tracers in patients with cardiac transthyretin amyloidosis (ATTR). METHODS: Data from 67 patients with ATTR who underwent both conventional whole-body scan and a CZT myocardial SPECT (DSPECT, Spectrum Dynamics) 3 h after injection of (99m)Tc-labeled bone tracer were analyzed. Visual scoring of cardiac retention was performed on whole-body scan according to Perugini 4-point grading system from 0 (no uptake) to 3 (strong cardiac uptake with mild/absent bone uptake). A planar heart-to-background (H:B) ratio was calculated using whole-body scan (wb-H:B). CZT SPECT was quantified using three methods: planar H:B ratio calculated from anterior reprojection (ant-H:B), left anterior oblique reprojection (LAO-H:B), and 3D-H:B ratio calculated from transaxial slices as mean counts in a VOI encompassing the heart divided by background VOI in the contralateral lung. Interventricular septal thickness was obtained using echocardiography. RESULTS: H:Bs obtained from planar and reprojected data were not statistically different (wb-H:B, 2.05 ± 0.64, ant-H:B, 1.97 ± 0.61, LAO-H:B, 2.06 ± 0.64, all p = ns). However, 3D-H:B was increased compared to planar H:Bs (3D-H:B, 4.06 ± 1.77, all p < 0.0001 vs. wb-H:B, ant-H:B, and LAO-H:B). Bland-Altman plots demonstrated that the difference between 3D and planar H:Bs increased with the mean value of myocardial uptake. 3D-H:B was best correlated to septal thickness (r = 0.45, p < 0.001). Finally, abnormal right ventricular uptake was associated with higher values of cardiac retention. CONCLUSION: 3D semi-quantitative analysis of CZT SPECT optimized the assessment of (99m)Tc-labeled bone tracer myocardial uptake in patients with cardiac amyloidosis.
format Online
Article
Text
id pubmed-6928186
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-69281862020-01-08 Quantification of myocardial (99m)Tc-labeled bisphosphonate uptake with cadmium zinc telluride camera in patients with transthyretin-related cardiac amyloidosis Manrique, Alain Dudoignon, David Brun, Stéphanie N’Ganoa, Catherine Cassol, Emmanuelle Legallois, Damien Lavie-Badie, Yoan Agostini, Denis Lairez, Olivier EJNMMI Res Original Research PURPOSE: We aimed to compare different methods for semi-quantitative analysis of cardiac retention of bone tracers in patients with cardiac transthyretin amyloidosis (ATTR). METHODS: Data from 67 patients with ATTR who underwent both conventional whole-body scan and a CZT myocardial SPECT (DSPECT, Spectrum Dynamics) 3 h after injection of (99m)Tc-labeled bone tracer were analyzed. Visual scoring of cardiac retention was performed on whole-body scan according to Perugini 4-point grading system from 0 (no uptake) to 3 (strong cardiac uptake with mild/absent bone uptake). A planar heart-to-background (H:B) ratio was calculated using whole-body scan (wb-H:B). CZT SPECT was quantified using three methods: planar H:B ratio calculated from anterior reprojection (ant-H:B), left anterior oblique reprojection (LAO-H:B), and 3D-H:B ratio calculated from transaxial slices as mean counts in a VOI encompassing the heart divided by background VOI in the contralateral lung. Interventricular septal thickness was obtained using echocardiography. RESULTS: H:Bs obtained from planar and reprojected data were not statistically different (wb-H:B, 2.05 ± 0.64, ant-H:B, 1.97 ± 0.61, LAO-H:B, 2.06 ± 0.64, all p = ns). However, 3D-H:B was increased compared to planar H:Bs (3D-H:B, 4.06 ± 1.77, all p < 0.0001 vs. wb-H:B, ant-H:B, and LAO-H:B). Bland-Altman plots demonstrated that the difference between 3D and planar H:Bs increased with the mean value of myocardial uptake. 3D-H:B was best correlated to septal thickness (r = 0.45, p < 0.001). Finally, abnormal right ventricular uptake was associated with higher values of cardiac retention. CONCLUSION: 3D semi-quantitative analysis of CZT SPECT optimized the assessment of (99m)Tc-labeled bone tracer myocardial uptake in patients with cardiac amyloidosis. Springer Berlin Heidelberg 2019-12-23 /pmc/articles/PMC6928186/ /pubmed/31873816 http://dx.doi.org/10.1186/s13550-019-0584-8 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Research
Manrique, Alain
Dudoignon, David
Brun, Stéphanie
N’Ganoa, Catherine
Cassol, Emmanuelle
Legallois, Damien
Lavie-Badie, Yoan
Agostini, Denis
Lairez, Olivier
Quantification of myocardial (99m)Tc-labeled bisphosphonate uptake with cadmium zinc telluride camera in patients with transthyretin-related cardiac amyloidosis
title Quantification of myocardial (99m)Tc-labeled bisphosphonate uptake with cadmium zinc telluride camera in patients with transthyretin-related cardiac amyloidosis
title_full Quantification of myocardial (99m)Tc-labeled bisphosphonate uptake with cadmium zinc telluride camera in patients with transthyretin-related cardiac amyloidosis
title_fullStr Quantification of myocardial (99m)Tc-labeled bisphosphonate uptake with cadmium zinc telluride camera in patients with transthyretin-related cardiac amyloidosis
title_full_unstemmed Quantification of myocardial (99m)Tc-labeled bisphosphonate uptake with cadmium zinc telluride camera in patients with transthyretin-related cardiac amyloidosis
title_short Quantification of myocardial (99m)Tc-labeled bisphosphonate uptake with cadmium zinc telluride camera in patients with transthyretin-related cardiac amyloidosis
title_sort quantification of myocardial (99m)tc-labeled bisphosphonate uptake with cadmium zinc telluride camera in patients with transthyretin-related cardiac amyloidosis
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6928186/
https://www.ncbi.nlm.nih.gov/pubmed/31873816
http://dx.doi.org/10.1186/s13550-019-0584-8
work_keys_str_mv AT manriquealain quantificationofmyocardial99mtclabeledbisphosphonateuptakewithcadmiumzinctelluridecamerainpatientswithtransthyretinrelatedcardiacamyloidosis
AT dudoignondavid quantificationofmyocardial99mtclabeledbisphosphonateuptakewithcadmiumzinctelluridecamerainpatientswithtransthyretinrelatedcardiacamyloidosis
AT brunstephanie quantificationofmyocardial99mtclabeledbisphosphonateuptakewithcadmiumzinctelluridecamerainpatientswithtransthyretinrelatedcardiacamyloidosis
AT nganoacatherine quantificationofmyocardial99mtclabeledbisphosphonateuptakewithcadmiumzinctelluridecamerainpatientswithtransthyretinrelatedcardiacamyloidosis
AT cassolemmanuelle quantificationofmyocardial99mtclabeledbisphosphonateuptakewithcadmiumzinctelluridecamerainpatientswithtransthyretinrelatedcardiacamyloidosis
AT legalloisdamien quantificationofmyocardial99mtclabeledbisphosphonateuptakewithcadmiumzinctelluridecamerainpatientswithtransthyretinrelatedcardiacamyloidosis
AT laviebadieyoan quantificationofmyocardial99mtclabeledbisphosphonateuptakewithcadmiumzinctelluridecamerainpatientswithtransthyretinrelatedcardiacamyloidosis
AT agostinidenis quantificationofmyocardial99mtclabeledbisphosphonateuptakewithcadmiumzinctelluridecamerainpatientswithtransthyretinrelatedcardiacamyloidosis
AT lairezolivier quantificationofmyocardial99mtclabeledbisphosphonateuptakewithcadmiumzinctelluridecamerainpatientswithtransthyretinrelatedcardiacamyloidosis